Parth Mehrotra Sells 21,097 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 21,097 shares of the business’s stock in a transaction that occurred on Tuesday, March 10th. The stock was sold at an average price of $22.71, for a total value of $479,112.87. Following the transaction, the chief executive officer owned 322,698 shares of the company’s stock, valued at approximately $7,328,471.58. This represents a 6.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Parth Mehrotra also recently made the following trade(s):

• On Monday, March 9th, Parth Mehrotra sold 41,999 shares of Privia Health Group stock. The shares were sold at an average price of $22.86, for a total value of $960,097.14.
• On Friday, March 6th, Parth Mehrotra sold 21,440 shares of Privia Health Group stock. The shares were sold at an average price of $23.15, for a total value of $496,336.00.

Privia Health Group Price Performance

Shares of Privia Health Group stock opened at $21.68 on Friday. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51. The business’s fifty day moving average price is $22.89 and its two-hundred day moving average price is $23.59. The company has a market capitalization of $2.68 billion, a P/E ratio of 127.53, a PEG ratio of 1.37 and a beta of 0.82.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Thursday, February 26th. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.21. The company had revenue of $541.17 million during the quarter, compared to analysts’ expectations of $516.61 million. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The company’s revenue for the quarter was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.21 earnings per share. On average, research analysts expect that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have commented on PRVA shares. Wolfe Research set a $31.00 target price on shares of Privia Health Group in a research note on Tuesday, January 6th. Royal Bank Of Canada began coverage on shares of Privia Health Group in a research note on Friday, January 9th. They issued an “outperform” rating and a $31.00 price target for the company. Jefferies Financial Group reiterated a “buy” rating and issued a $32.00 price objective on shares of Privia Health Group in a report on Thursday, February 26th. Citigroup lowered their price objective on shares of Privia Health Group from $34.00 to $32.00 and set a “buy” rating on the stock in a research note on Tuesday, March 3rd. Finally, Truist Financial boosted their target price on Privia Health Group from $31.00 to $33.00 and gave the stock a “buy” rating in a report on Monday, March 2nd. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $31.00.

Institutional Investors Weigh In On Privia Health Group

Institutional investors and hedge funds have recently bought and sold shares of the business. Van Berkom & Associates Inc. grew its stake in shares of Privia Health Group by 30.1% in the 3rd quarter. Van Berkom & Associates Inc. now owns 3,774,565 shares of the company’s stock worth $93,987,000 after purchasing an additional 873,344 shares during the last quarter. Vanguard Group Inc. lifted its stake in Privia Health Group by 5.3% during the third quarter. Vanguard Group Inc. now owns 12,098,933 shares of the company’s stock valued at $301,263,000 after purchasing an additional 607,447 shares during the last quarter. ArrowMark Colorado Holdings LLC lifted its stake in Privia Health Group by 139.4% during the fourth quarter. ArrowMark Colorado Holdings LLC now owns 841,266 shares of the company’s stock valued at $19,946,000 after purchasing an additional 489,866 shares during the last quarter. Algert Global LLC boosted its holdings in Privia Health Group by 277.4% during the third quarter. Algert Global LLC now owns 484,304 shares of the company’s stock worth $12,059,000 after buying an additional 355,966 shares in the last quarter. Finally, Freestone Grove Partners LP boosted its holdings in Privia Health Group by 40.6% during the fourth quarter. Freestone Grove Partners LP now owns 1,213,342 shares of the company’s stock worth $28,768,000 after buying an additional 350,194 shares in the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.